决奈达隆杂质，艾曲波帕杂质对照品

 决奈达隆杂质，艾曲波帕杂质对照品  产品介绍：
中文名称： 决奈达隆杂质，艾曲波帕杂质对照品 
英文名称：
规格：10mg/25mg/50mg/100mg等多种规格可选。
用途：实验研发，药品申报检测，不得用于临床医学诊断。
随货提供：所有杂质对照品均随货提供HPLC，NMR，MS图谱及CoA证书。
保存及取用：为了防止产品含量降低，应防潮，避光和抗氧化包装，保存应以提高物质稳定性为原则。如果一次使用很少量，可以将其适当分装后使用，这样可以有效的防止试剂污染。请不要在脏乱和强光环境中取用，以免造成污染和失效。

 决奈达隆杂质，艾曲波帕杂质对照品 杂质列表：

Dronedarone	N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)benzofuran-5-yl)methanesulfonamide
Dronedarone Impurity 1	N-(3-(4-(3-aminopropoxy)benzoyl)-2-butylbenzofuran-5-yl)methanesulfonamide hydrochloride
Dronedarone Impurity 2	N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)benzofuran-5-yl)formamide hydrochloride
Dronedarone Impurity 3	N-butyl-N-(3-(4-(2-butyl-5-(methylsulfonamido)benzofuran-3-carbonyl)phenoxy)propyl)butan-1-amine oxide
Dronedarone Impurity 4	N-[2-Butyl-3-[4-[3-(butylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide hydrochloride
Dronedarone Impurity 5	(5-amino-2-butylbenzofuran-3-yl)(4-(3-(dibutylamino)propoxy)phenyl)methanone methanone dioxalate
Dronedarone Impurity 6	(5-amino-2-butylbenzofuran-3-yl)(4-hydroxyphenyl)methanone
Dronedarone Impurity 7	(2-butyl-5-nitrobenzofuran-3-yl)(4-hydroxyphenyl)methanone
Dronedarone Impurity 8	N-(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)benzofuran-5-yl)-N-(methylsulfonyl)methanesulfonamide hydrochloride
Dronedarone Impurity 9	(2-butyl-5-nitrobenzofuran-3-yl)(4-methoxyphenyl)methanone
Dronedarone Impurity 10	(5-amino-2-butylbenzofuran-3-yl)(4-(3-aminopropoxy)phenyl)methanone
Dronedarone Impurity 11	(2-butyl-3-(4-(3-(dibutylamino)propoxy)benzoyl)benzofuran-5-yl)sulfamoyl chloride hydrochloride
Dronedarone Impurity 12	N,N'-(3,3'-(4,4'-(propane-1,3-diylbis(oxy))bis(benzoyl))bis(2-butylbenzofuran-5,3-diyl))dimethanesulfonamide
Dronedarone Impurity 13	Methyl 2-(2-forMyl-4-nitrophenoxy)hexanoate
Dronedarone Impurity 14	2-(2-forMyl-4-nitrophenoxy)hexanoic acid
Eltrombopag	(Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag Impurity 1	5'-chloro-2'-hydroxy-3'-nitro-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag Impurity 2	3'-amino-5'-chloro-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag Impurity 3	3'-amino-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag Impurity 4	1-(3,4-dimethylphenyl)-3-methyl-1H-pyrazol-5(4H)-one
Eltrombopag Impurity 5	1-(3,4-dimethylphenyl)-4-(hydroxyamino)-3-methyl-1H-pyrazol-5(4H)-one
Eltrombopag Impurity 6	(E)-1-(3,4-dimethylphenyl)-4-(hydroxyimino)-3-methyl-1H-pyrazol-5(4H)-one
Eltrombopag Impurity 7	(Z)-5'-chloro-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag Impurity 8	5',5''-bis((Z)-2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-4'',6'-dihydroxy-[1,1':3',1'':3'',1'''-quaterphenyl]-3,3'''-dicarboxylic acid
Eltrombopag Impurity 9	(Z)-ethyl 3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate
Eltrombopag Impurity 10	1',2-bis(3,4-dimethylphenyl)-3-hydroxy-3',5-dimethyl-3,4-dihydro-1'H,2H-[3,4'-bipyrazol]-5'(4'H)-one
Eltrombopag Impurity 11	(2R,3R,4R,5S,6R)-6-((3'-((Z)-2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)-1-hydroxyhydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carbonyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Eltrombopag Impurity 12	3'-acetamido-2'-(((3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag Impurity 13	(Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxamide
Eltrombopag Impurity 14	(Z)-methyl 3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylate
Eltrombopag Impurity 15	(E)-5'-chloro-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)-1-hydroxyhydrazinyl)-2'-hydroxy-[1,1'-biphenyl]-3-carboxylic acid
Eltrombopag Impurity 16	1-(4-ethoxyphenyl)-5-(2-hydroxy-4-methoxybenzoyl)pyridin-2(1H)-one
Eltrombopag Impurity 17	(Z)-3'-(2-(1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1H-pyrazol-4(5H)-ylidene)hydrazinyl)-2'-methoxy-[1,1'-biphenyl]-3-carboxylic acid

若杂质列表中未有您需要的杂质，欢迎来电或在线详询，产品库时常会有更新，另外，我司有专业研发团队，可提供部分杂质定制服务，以最大可能的满足您对杂质对照品的选购需求。

 决奈达隆杂质，艾曲波帕杂质对照品 订购方式：
联系人：何先生
手机：15012456311
QQ：781007885
邮箱：phastandards@gmail.com
欢迎您通过电话，电邮或在线客服向我司询价及订购产品。

 决奈达隆杂质，艾曲波帕杂质对照品 作用机理：
 日前，美国 FDA 批准葛兰素史克艾曲波帕 (Eltrombopag) 补充新药申请(sNDA)，用于对免疫抑制疗法(IST) 没有充分响应的严重型再生障碍性贫血 (SAA) 患者治疗。艾曲波帕是一种促血小板生成素 (TPO) 受体激动剂，为了增加血细胞的产生，日服一次艾曲波帕会帮助诱导骨髓干细胞的增殖和分化。

 决奈达隆杂质，艾曲波帕杂质对照品  深圳远扬专注医药标准品，杂质对照品，更多产品，欢迎选购（篇幅有限，只列举了一小部分，更多更全，请来电详询）：
杂质对照品部分产品列表：
多西他赛杂质，阿司咪唑杂质，硝呋太尔杂质，孟鲁司特钠杂质，埃博霉素B杂质，鲁比前列酮杂质，利伐普坦杂质，卡非佐米杂质，夫西地酸杂质，异舒普林杂质，安塞曲匹杂质，阿哌沙班杂质，左西替利嗪杂质，头孢噻肟杂质，西地那非杂质，哌拉西林杂质，氟哌利多杂质，帕唑帕尼杂质，坎格瑞洛杂质，阿达帕林杂质，阿塞那平杂质，罗库溴铵杂质，匹杉琼杂质，夫罗曲坦杂质，阿戈美拉汀杂质，普芦卡必利杂质，鲁格列净杂质，克拉霉素杂质，吡嗪酰胺杂质，非洛地平杂质，青蒿琥酯杂质，盐酸多佐胺杂质，替诺福韦酯杂质，吉法酯杂质，依佐加滨杂质，普瑞巴林杂质，咪达那新杂质，瑞格列奈杂质，米氮平杂质，泼尼松龙杂质，氟马西尼杂质，马尼地平杂质，溴芬酸钠杂质，达巴万星杂质，泮托拉唑杂质，奥美拉唑杂质，地塞米松杂质，利奈唑胺杂质，比卡鲁胺杂质，头孢克洛杂质，美洛昔康杂质，乐卡地平杂质，氯马斯汀杂质，西地那非杂质，盐酸瑞伐拉赞杂质，沙芬酰胺杂质，阿托伐他汀杂质，替莫唑胺杂质，沙格列汀杂质